Lincoff, A M, Nicholls, S J, Riesmeyer, J S, Barter, P J, Brewer, H B, Fox, K A A, Gibson, C M, Granger, C, Menon, V, Montalescot, G, Rader, D, Tall, A R, McErlean, E, Wolski, K, Ruotolo, G, Vangerow, B, Weerakkody, G, Goodman, S G, Conde, D, McGuire, D K, Nicolau, J C, Leiva-Pons, J L, Pesant, Y, Li, W, Kandath, D, Kouz, S, Tahirkheli, N & Mason, D & Nissen, S E 2017, ' Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease ', New England Journal of Medicine, vol. 376, no. 20, pp. 1933-1942 . https://doi.org/10.1056/NEJMoa1609581
New England Journal of Medicine New England Journal of Medicine, Massachusetts Medical Society, 2019, 380 (4), pp.347-357. ⟨10.1056/NEJMoa1812389⟩ NEW ENGLAND JOURNAL OF MEDICINE
Holman, R R, Bethel, M A, Mentz, R J, Thompson, V P, Lokhnygina, Y, Buse, J B, Chan, J C, Choi, J, Gustavson, S M, Iqbal, N, Maggioni, A P, Marso, S P, Öhman, P, Pagidipati, N J, Poulter, N, Ramachandran, A, Zinman, B, Hernandez, A F, EXSCEL Study Group & Serné, EH 2017, ' Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes ', New England Journal of Medicine, vol. 377, no. 13, pp. 1228-1239 . https://doi.org/10.1056/NEJMoa1612917 New England Journal of Medicine, 377(13), 1228-1239. Massachussetts Medical Society N Engl J Med